ADMA Biologics, Inc. (ADMA) stock
ADMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 17/3028% below fair value
$13.63+0.16 (+1.19%)
Close on Nov 17, 2026Market cap $3.05BP/E 19.5Yield –
ADMA Biologics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
ADMA Biologics's market cap was $2.97B on Nov 11, 2026, against $4.57B a year earlier. Over the last 5 years it ranged from $195.02M to $5.63B, with a median of $1.94B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $2.97B | -31.6% |
| 2025 | Dec 31, 2025 | $4.35B | +7.2% |
| 2024 | Dec 31, 2024 | $4.05B | +296.9% |
| 2023 | Dec 29, 2023 | $1.02B | +33.8% |
| 2022 | Dec 30, 2022 | $763.49M | +291.5% |
| 2021 | Dec 31, 2021 | $195.02M | +11.6% |
| 2020 | Dec 31, 2020 | $174.75M | -26.4% |
| 2019 | Dec 31, 2019 | $237.27M | +114.2% |
| 2018 | Dec 31, 2018 | $110.78M | +100.6% |
| 2017 | Dec 29, 2017 | $55.22M | -16.3% |
| 2016 | Dec 30, 2016 | $65.98M | -23.7% |
| 2015 | Dec 31, 2015 | $86.45M | -16.7% |
| 2014 | Dec 31, 2014 | $103.79M | +126.6% |
| 2013 | Dec 31, 2013 | $45.79M | – |
See a number that looks wrong?